HIGH-DOSE HEPARIN SUPPRESSES PLATELET ALPHA GRANULE SECRETION

被引:23
作者
ROHRER, MJ
KESTIN, AS
ELLIS, PA
BARNARD, MR
RODINO, L
BRECKWOLDT, WL
LI, JM
MICHELSON, AD
SUMPIO, B
机构
[1] UNIV MASSACHUSETTS, SCH MED, DIV VASC SURG, WORCESTER, MA 01605 USA
[2] UNIV MASSACHUSETTS, SCH MED, DEPT PEDIAT, WORCESTER, MA 01605 USA
[3] MED CTR CENT MASSACHUSETTS MEM, DIV HEMATOL, WORCESTER, MA USA
关键词
D O I
10.1016/0741-5214(92)90456-I
中图分类号
R61 [外科手术学];
学科分类号
摘要
Platelet degranulation has been implicated in the pathophysiology of acute arterial thrombosis, intimal hyperplasia, and atherogenesis. Most previous studies that examined the effect of heparin on platelet function have used platelet aggregometry. These studies have resulted in contradictory data and, by the nature of the assay, reveal no information with regard to platelet degranulation. In contrast, flow cytometry allows accurate quantification of the extent of platelet degranulation by measurement of the platelet surface binding of a GMP-140 specific monoclonal antibody (S12). GMP-140 is only expressed on the platelet surface after platelet alpha-granule release. In the present study increasing concentrations of heparin were added to whole blood anticoagulated with sodium citrate. Platelets were activated with a panel of agonists, and the extent of platelet degranulation was quantified by whole blood flow cytometry. Heparin concentrations as high as 100 units/ml were found to suppress platelet alpha-granule release induced by either a thromboxane A2 analog (U46619) or a combination of adenosine diphosphate and epinephrine. Heparin suppressed alpha-granule release induced by thrombin both in whole blood and in washed platelets. The addition of heparin after platelet activation had no effect on S12 binding. In summary, heparin in high concentrations is a potent inhibitor of platelet degranulation, an action that is unrelated to its effect on the coagulation cascade. Although the heparin concentrations used in this study exceed those used clinically by a factor of 10 or more, future studies of heparin fractions may allow the separation of the anticoagulant and antiplatelet properties of the molecule and allow the administration of an agent that selectively suppresses platelet degranulation without the humoral anticoagulant effect.
引用
收藏
页码:1000 / 1009
页数:10
相关论文
共 58 条
[1]  
ABRAMS C, 1991, THROMB HAEMOSTASIS, V65, P467
[2]   ISOLATION OF THE THROMBOSPONDIN MEMBRANE-RECEPTOR [J].
ASCH, AS ;
BARNWELL, J ;
SILVERSTEIN, RL ;
NACHMAN, RL .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) :1054-1061
[3]  
BARNETT HJM, 1987, HEMOSTASIS THROMBOSI, P1301
[4]   HEPARIN EFFECTS ON PLASMA LYSOLECITHIN FORMATION AND PLATELET-AGGREGATION [J].
BESTERMA.EM ;
GILLETT, MPT .
ATHEROSCLEROSIS, 1973, 17 (03) :503-513
[5]  
BLAJCHMAN MA, 1989, ANN NY ACAD SCI, V556, P245
[6]   AN OBJECTIVE ASSESSMENT OF THE INTERACTION OF HEPARIN AND ITS FRACTIONS WITH HUMAN-PLATELETS [J].
BRACE, LD ;
FAREED, J .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1985, 11 (02) :190-198
[7]   HISTAMINE AND THE HUMAN-HEART - THE OTHER RECEPTOR SYSTEM [J].
BRISTOW, MR ;
GINSBURG, R ;
HARRISON, DC .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (01) :249-251
[8]   REGULATION OF VASCULAR SMOOTH-MUSCLE CELL-GROWTH BY HEPARIN AND HEPARAN SULFATES [J].
CASTELLOT, JJ ;
WRIGHT, TC ;
KARNOVSKY, MJ .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1987, 13 (04) :489-503
[9]  
CHERVU A, 1990, SEMIN VASC SURG, V3, P21
[10]   SUPPRESSION BY HEPARIN OF SMOOTH-MUSCLE CELL-PROLIFERATION IN INJURED ARTERIES [J].
CLOWES, AW ;
KARNOWSKY, MJ .
NATURE, 1977, 265 (5595) :625-626